Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PMC Biogenix is a specialty chemicals company focused on developing, manufacturing, and marketing oleochemical derivatives and other renewable-resource-based chemical products. The business operates as part of PMC Group and serves industrial end markets including polymers and plastics, lubricants and greases, metalworking, crop protection, and chemical manufacturing. Its portfolio includes branded fatty acids, amides, esters, stearates, waxes, and related additives sold under names such as Armoslip, Hystrene, Kemamide, Kemester, and ADVALUBE. The company has historically operated an integrated manufacturing and technical development site in Memphis, Tennessee, along with a primary amides facility in Gyeongju, South Korea. Although PMC Biogenix supplies some pharmaceutical-grade ingredients, it is not primarily a biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PMC Biogenix.